Drawing for SPEAR DERMATOLOGY PRODUCTS

USPTO serial 97829298

SPEAR DERMATOLOGY PRODUCTS

Reviewed by CopyMark Law Group

Reg. 7444687Status 700Registered
Filing date
Status date
Registration date
Jul 9, 2024
Examiner
MMEJE, OBIEZE GINIKANWA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SPEAR DERMATOLOGY PRODUCTS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William E. Noonan

William E. Noonan WILLIAM E. NOONAN, ATTORNEY AT LAWPOB 07338FORT MYERS, FL 33919United States

Goods and services

ClassDescriptionStatusFirst use
005Dermatological pharmaceutical products; Dermatologicals; Medicated dermatological preparations and substances; Medicated creams for treating dermatological conditions; Creams for dermatological use; Gels for dermatological use; Gels, creams and solutions for dermatological use; Medicated lotions for treating dermatological conditions; Medicated ointments for treating dermatological conditionsACTIVEDec 31, 1999

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 9, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 9, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 31, 2024SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
May 31, 2024CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
May 3, 2024SUPCSTATEMENT OF USE PROCESSING COMPLETE—
May 3, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 12, 2024IUAFUSE AMENDMENT FILED—
Apr 12, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 24, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 29, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 29, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 9, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 26, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 25, 2023DOCKASSIGNED TO EXAMINER—
Mar 29, 2023MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Mar 28, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 11, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance